ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comprehensive Metabolic Profiling of Inflammation Indicated Key Roles of Glycerophospholipid and Arginine Metabolism in Coronary Artery Disease

Zhu, Qian; Wu, Yonglin; Mai, Jinxia; Guo, Gongjie; Meng, Jinxiu; Fang, Xianhong; Chen, Xiaoping; Liu, Chen; Zhong, Shilong*广东省人民医院; 广东省心血管病研究所; 南方医科大学; 中山大学; 1
Frontiers in Immunology2022-3-8DOI: 10.3389/fimmu.2022.829425
21被引8阅读
引用收藏
分享

摘要

BackgroundSystemic immune inflammation is a key mediator in the progression of coronary artery disease (CAD), concerning various metabolic and lipid changes. In this study, the relationship between the inflammatory index and metabolic profile in patients with CAD was investigated to provide deep insights into metabolic disturbances related to inflammation. MethodsWidely targeted plasma metabolomic and lipidomic profiling was performed in 1,234 patients with CAD. Laboratory circulating inflammatory markers were mainly used to define general systemic immune and low-grade inflammatory states. Multivariable-adjusted linear regression was adopted to assess the associations between 860 metabolites and 7 inflammatory markers. Least absolute shrinkage and selection operator (LASSO) logistic-based classifiers and multivariable logistic regression were applied to identify biomarkers of inflammatory states and develop models for discriminating an advanced inflammatory state. ResultsMultiple metabolites and lipid species were linearly associated with the seven inflammatory markers [false discovery rate (FDR) <0.05]. LASSO and multivariable-adjusted logistic regression analysis identified significant associations between 45 metabolites and systemic immune-inflammation index, 46 metabolites and neutrophil-lymphocyte ratio states, 32 metabolites and low-grade inflammation score, and 26 metabolites and high-sensitivity C-reactive protein states (P < 0.05). Glycerophospholipid metabolism and arginine and proline metabolism were determined as key altered metabolic pathways for systemic immune and low-grade inflammatory states. Predictive models based solely on metabolite combinations showed feasibility (area under the curve: 0.81 to 0.88) for discriminating the four parameters that represent inflammatory states and were successfully validated using a validation cohort. The inflammation-associated metabolite, namely, beta-pseudouridine, was related to carotid and coronary arteriosclerosis indicators (P < 0.05). ConclusionsThis study provides further information on the relationship between plasma metabolite profiles and inflammatory states represented by various inflammatory markers in CAD. These metabolic markers provide potential insights into pathological changes during CAD progression and may aid in the development of therapeutic targets.

学科与关键词

关键词
coronary artery diseasemetabolomelipidomeinflammationglycerophospholipid metabolismarteriosclerosis
相关
加载中…
  • Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease Progression
    Chen, Hui; Wang, Zixian; Qin, Min; Zhang, Bin; Lin, Lu; Ma, Qilin; Liu, Chen; Chen, Xiaoping; Li, Hanping; Lai, Weihua; Zhong, Shilong*Frontiers in Molecular Biosciences, 2021, 8: 632950.被引 14
  • Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease
    Zhu, Qian; Qin, Min; Wang, Zixian; Wu, Yonglin; Chen, Xiaoping; Liu, Chen; Ma, Qilin; Liu, Yibin; Lai, Weihua; Chen, Hui; Cai, Jingjing; Liu, Yemao; Lei, Fang; Zhang, Bin; Zhang, Shuyao; He, Guodong; Li, Hanping; Zhang, Mingliang; Zheng, Hui; Chen, Jiyan; Huang, Min; Zhong, Shilong*Cell and Bioscience, 2022, 12(1): 173.被引 3
  • Association Between Systemic Immune Inflammation Level and Poor Prognosis Across Different Glucose Metabolism Status in Coronary Artery Disease Patients
    Xu, Xiayan; Xie, Yun; Gu, Xia; Zhou, Yang; Kang, Yu; Liu, Jin; Lai, Wenguang; Lu, Hongyu; Chen, Shiqun; Xu, Jun-yan; Lin, Feng*; Liu, Yong*Journal of Inflammation Research, 2023, 16: 4031-4042.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-03-08
卷期
第 13 卷
页码
829425
DOI
10.3389/fimmu.2022.829425
语言
ENGLISH
期刊等级
2区
成果收录
SCIE

作者

  • Z

    Zhu, Qian (第一作者)

    guangdong prov peoples hosp

  • W

    Wu, Yonglin

    southern med univ

查看全部 9 位作者收起作者
  • M

    Mai, Jinxia

    southern med univ

  • G

    Guo, Gongjie

    guangdong prov peoples hosp

  • M

    Meng, Jinxiu

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • F

    Fang, Xianhong

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • C

    Chen, Xiaoping

  • L

    Liu, Chen

    1 · sun yat sen univ

  • Z

    Zhong, Shilong (通讯)

    southern med univ · guangdong cardiovasc inst · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417